In recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $110.45, changing hands for $119.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.